ERBB2 and breast cancer: Given IKKβ’s role in hormone-independent HER2+ breast cancer and evidence showing the potential of the curcumin as a IKKβ inhibitor, curcumin may exert its PAM-mediated effect on MDA-MB-453, at least in part, in this way [46,47].